Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Agid

Showing results (351-360 of 611) with videos related to

Pageof 62
Sort By:
Neurology|July 26, 2000
Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesisI Arnulf, A M Bonnet, P Damier, et al.
Human Mutation|February 5, 1998
Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph diseaseG Cancel, I Gourfinkel-An, G Stevanin, et al.
Brain Research. Molecular Brain Research|March 1, 1994
Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalonV Blanchard, R Raisman-Vozari, S Vyas, et al.
Journal of the Neurological Sciences|September 1, 1988
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsyL Pierot, C Desnos, J Blin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1989
Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer diseaseS Lehéricy, E C Hirsch, P Cervera, et al.
Advances in Neurology|January 1, 1987
Relationship of aging to Parkinson's diseaseW Koller, R O'Hara, W Weiner, et al.
Revue Neurologique|August 1, 1977
[Abnormal movements caused by L-DOPA in patients with Parkinson's disease: correlation with the plasma concentrations of DOPA and O-methyl-DOPA]F Lhermitte, Y Agid, C Feuerstein, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Somatostatin alterations and brain diseasesJ Epelbaum, Y Agid, A Enjalbert, et al.
Brain Research|June 24, 1985
Dissociation of neuropeptide Y and somatostatin in Parkinson's diseaseJ M Allen, A J Cross, T J Crow, et al.
Neurology|July 1, 1994
The phenotype of "pure" autosomal dominant spastic paraplegiaA Dürr, A Brice, M Serdaru, et al.
Pageof 62

Showing results (351-360 of 611) with videos related to

Sort By:
Pageof 62
Neurology|July 26, 2000
Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesisI Arnulf, A M Bonnet, P Damier, et al.
Human Mutation|February 5, 1998
Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph diseaseG Cancel, I Gourfinkel-An, G Stevanin, et al.
Brain Research. Molecular Brain Research|March 1, 1994
Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalonV Blanchard, R Raisman-Vozari, S Vyas, et al.
Journal of the Neurological Sciences|September 1, 1988
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsyL Pierot, C Desnos, J Blin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1989
Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer diseaseS Lehéricy, E C Hirsch, P Cervera, et al.
Advances in Neurology|January 1, 1987
Relationship of aging to Parkinson's diseaseW Koller, R O'Hara, W Weiner, et al.
Revue Neurologique|August 1, 1977
[Abnormal movements caused by L-DOPA in patients with Parkinson's disease: correlation with the plasma concentrations of DOPA and O-methyl-DOPA]F Lhermitte, Y Agid, C Feuerstein, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Somatostatin alterations and brain diseasesJ Epelbaum, Y Agid, A Enjalbert, et al.
Brain Research|June 24, 1985
Dissociation of neuropeptide Y and somatostatin in Parkinson's diseaseJ M Allen, A J Cross, T J Crow, et al.
Neurology|July 1, 1994
The phenotype of "pure" autosomal dominant spastic paraplegiaA Dürr, A Brice, M Serdaru, et al.
Pageof 62